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Lymphangiomyomatosis (LAM) is a rare lung disease that is characterized by the progressive proliferation of atypical 
smooth muscle-like cells, which leads to severe respiratory impairment and death. Dyspnea, cough, recurrent 
pneumothorax, and hemoptysis are the most common clinical symptoms of LAM. We report a 29-year-old female 
patient with massive hemoptysis during laparoscopic gynecologic surgery under general anesthesia, who was 
diagnosed with pulmonary LAM. (Korean J Anesthesiol 2012; 62: 371-374)
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CC
Lymphangiomyomatosis (LAM) is a rare lung disease that 
is characterized pathologically by cysts and multifocal nodular 
proliferation of immature smooth muscle and perivascular 
epitheloid cells (LAM cells) [1]. LAM usually presents with 
the symptoms of progressive dyspnea, cough, recurrent 
pneumothorax, chylothorax, and hemoptysis. Most cases of 
LAM occur in women of reproductive age [1-3].
Detecting the disease at a pre-operative evaluation is very 
difficult because it does not show any specific symptoms at the 
early stages, and the chest x-ray findings are normal. We report 
an ectopic pregnant patient, who was normal at a pre-operative 
chest x-ray, with massive hemoptysis during laparoscopic 
gynecologic surgery under general anesthesia. The patient was 
diagnosed with LAM by high resonance computed tomography 
(HRCT) and biopsy after surgery. 
Case Report
A 29-year-old, 54kg female patient with a right fallopian 
pregnancy was admitted for emergent pelviscopic salpin-
gectomy. Her past history and familial history were not specific. 
The preoperative ECG, chest x-ray (Fig. 1), and laboratory study 
were within normal range.
When she arrived in the operating room, the ECG, non-
invasive blood pressure device, and pulse oximeter were 
applied. Her blood pressure (BP), heart rate (HR) and oxygen 
saturation (SpO2) was 110/70 mmHg, 87 bpm and 99%, 
respectively. Thiopental sodium 250 mg and rocuronium 50 
mg were injected. After 3 minutes of manual ventilation with 
O2 2 L/min, N2O 4 L/min and sevoflurane 4 vol%, she was 
intubated with an internal diameter 7.0 mm endotracheal tube 
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under direct laryngoscopy. No problems were encountered 
during tracheal intubation and the breathing sound was clear 
at both lung fields. Mechanical ventilation was conducted as 
a tidal volume of 500 ml and respiratory rate of 10 breaths/
min, and anesthesia was maintained with O2 2 L/min, N2O 2 L/
min and sevoflurane 2.5 vol%. Her vital signs at this time were 
a BP of 140/90 mmHg, HR of 105 bpm, SpO2 of 99%, end-tidal 
carbon dioxide partial pressure (PETCO2) of 28 mmHg, and peak 
inspiratory pressure of 14 cmH2O. The position of the patient 
was changed to the Trendelenburg position at 10 minutes 
after the skin incision. Her vital signs were stable during the 
operation, and the peak inspiratory pressure was 20-22 cmH2O 
during pneumoperitoneum. Inhalation anesthetics were 
stopped and the lungs were ventilated with 100% O2 during 
skin closure. The patient received pyridostigmine 10 mg and 
glycopyrrolate 0.4 mg to reverse the neuromuscular block.
When she breathed spontaneously, a large amount of fresh 
blood was found in endotracheal tube with cough. At this point, 
her BP, HR, and SpO2 were 150/105 mmHg, 125 bpm, and 100%, 
respectively. Hemoptysis occurred several times but the amount 
of bleeding decreased gradually. The total amount of blood 
loss was approximately 300 ml. Her mental status became alert 
and 93% SpO2 by spontaneous respiration with endotracheal 
tube was sustained with room air. An airway injury was 
evaluated due to endotracheal intubation by using fiberoptic 
bronchoscope but there were no specific finding in the trachea 
and main bronchus. No intraoral bleeding was observed.
Her vital signs were gradually stable but she was transferred 
to ICU with endotracheal tube for the evaluation and the further 
management of hemoptysis. At ICU, BP was 110-120/70-80 
mmHg, HR was 80-90 bpm, and ABGA with a FiO2 0.4 was pH 
7.42, PaO2 117 mmHg, PaCO2 32 mmHg, HCO3 21.9 mmol/L, BE 
-2.2 mmol/L, and SaO2 99% at with spontaneous ventilation. 
Postoperative chest x-ray showed that infiltration on both lung 
fields, especially left lung, was increased, and consolidation 
with air bronchogram was found (Fig. 2). No more hemoptysis 
was complained except for a small amount of blood in the 
endotracheal tube during suction, so the patient was extubated 
10 hours after surgery. After extubation, she was stable, and 
did not complain of dyspnea without an oxygen supply. HRCT 
to evaluate the cause of hemoptysis revealed multiple cystic 
changes in the total lung field (Fig. 3). From the findings of 
HRCT, the characteristic symptoms and ectopic pregnancy of 
the patient, she was diagnosed with LAM, which was confirmed 
by a lung biopsy.
Fig. 1. The preoperative chest x-ray shows normal finding.
Fig. 2. The postoperative chest x-ray shows increased infiltration and 
consolidation with air-bronchogram.
Fig. 3. The CT scan shows numerous well defined, thin-walled round 
or oval shaped cysts throughout the lungs.373 www.ekja.org
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Discussion
LAM is known as a rare lung disease, which occurs mostly 
in reproductive aged women, but has been reported in men 
[4]. LAM occurs in sporadically or in association with tuberous 
sclerosis, and can develop anywhere that lymphatic tissues 
exist, such as perivascular, perilymphangeal, alveolar wall, or 
peri-bronchial area [5]. Cornog and Enterline [6] first referred 
to this disease as LAM in 1966 to distinguish it from tuberous 
sclerosis because the pathological findings of mediastinal 
lymphangiomyoma along with chylothorax are similar to the 
proliferation of smooth muscle cells of tuberous sclerosis. 
According to the European Respiratory Society guideline in 
2010 [1], sporadic LAM occurs ~1 in 400,000 adult women; in 
tuberous sclerosis complex, LAM occurs in 30-40% of adult 
women.
Once the pulmonary symptoms manifest, it is mostly 
aggravated to pulmonary failure or cor pulmonale, and leads to 
death in 10 years. The most common pulmonary symptoms are 
dyspnea, cough, hemoptysis, and pneumothorax with an abrupt 
onset, etc. Pleural effusion and intraabdominal hemorrhage 
can be accompanied. The symptoms characteristically can be 
aggravated by pregnancy. Once the bronchioles are obstructed 
by proliferating smooth muscle cells, the clinical features of 
obstructive lung disease are shown but a pneumothorax can 
also occur because air retention increases the size of the alveoli 
and produces bullae or cysts. The invasion of blood vessels 
and lymphatics are the cause of hemoptysis and chylothorax, 
respectively [7].
Generally, LAM is suspected by the characteristic clinical 
features in reproductive aged women, obstructive patterns of 
the pulmonary function, increased lung volume, defect gas 
exchange, and reticulonodular interstitial infiltrates on the 
chest x-ray. The pathological findings by a lung biopsy has been 
used for confirmation in the past, but the cystic changes in 
HRCT and accompanying characteristic clinical features allow 
a diagnosis without a biopsy [2]. There is no definite treatment 
that effectively reverses the functional abnormalities or stops 
the progressing lung injury in LAM. Because LAM is mostly a 
disease of reproductive aged women and can worsen during 
pregnancy [1,8,9], female hormonal therapy has been utilized. 
The hormonal therapy includes oophorectomy [10], tamoxifen 
[11] and gonadotropin-release hormone analogues [12] as a 
method of anti-estrogen. On the other hand, progesterone 
treatment [1] is preferably recommended at present. The 
symptomatic treatment for the condition includes standard 
therapies for obstructive pulmonary disease and operation for 
a recurrent pneumothorax [4]. In addition, LAM is one of the 
indications of lung transplantation, and it has a high success 
rate [13].
LAM patients commonly complain of dyspnea as the first 
clinical symptom. On the other hand, in this case, she did not 
complain of dyspnea or cough before the operation and had 
abrupt massive hemoptysis as the first symptom. The common 
causes of hemoptysis during anesthesia are airway injury by 
endotracheal intubation, pneumonia, bronchitis, tuberculosis, 
or tumors, etc. Tracheal injury could be ruled out by a fiberoptic 
bronchoscopy examination in this case. Pneumonia and 
bronchitis also could be ruled out as a cause of the hemoptysis 
because the hemoptysis in pneumonia and bronchitis is 
characterized as blood-tinged sputum rather than massive 
bleeding. Normally, tuberculosis and tumors can be diagnosed 
preoperatively by chest x-ray. 
In this patient, LAM was not suspected before surgery 
because she had no medical history and no specific findings 
on the chest x-ray. It is unclear why her disease progressed 
abruptly. In our opinion, there were several aggravating factors. 
First, she became ectopic pregnant recently, which may have 
aggravated the LAM [4,8,9]. Second, the most important 
cause of hemoptysis is mechanical ventilation during general 
anesthesia for surgery due to an ectopic pregnancy [4,5,14]. 
Moreover, the use of N2O can be the cause of hemoptysis 
because she had cystic changes in her lung [3,4]. Finally, 
the specific requirement for the pelviscopic surgery, such as 
Trendelenburg position and pneumoperitoneum increased the 
airway pressure [15], which may have aggravated the lung injury 
and led to hemoptysis.
Most LAM patients meet anesthesiologists for the surgical 
treatment of a recurrent pneumothorax or pregnant women 
to have painless labor or a cesarean section. Anesthetic 
management for LAM patients is related mainly to pulmonary 
complications. The complications include pneumothorax 
or intrapulmonary bleeding due to the severe obstruction of 
the bronchioles as well as cystic changes in the pulmonary 
parenchyma during mechanical ventilation. Because of 
pulmonary complications due to mechanical ventilation, 
regional anesthesia is preferred over general anesthesia. 
It is expected that epidural anesthesia is safer than spinal 
anesthesia because hydration for hemodynamic stability 
during spinal anesthesia can cause pulmonary edema [14]. 
Furthermore, epidural anesthesia allowed careful titration 
and avoidance of a high motor block, which would have been 
catastrophic to someone with such limited respiratory reserve 
[5]. When general anesthesia is requested, nitrous oxide 
should be avoided in patients with cystic lung disease or a 
closed pneumothorax, and a mechanical ventilator strategy to 
decrease airway pressure is needed [4].
In conclusion, this paper reported the occurrence of hemo-
ptysis due to mechanical ventilation during general anesthesia 
in a LAM patient with pulmonary cystic changes, who did not 374 www.ekja.org
Vol. 62, No. 4, April 2012 Lymphangiomyomatosis and hemoptysis
show any signs of LAM before operation. The possibility of 
LAM should be considered if a reproductive aged woman has 
unexplained massive hemoptysis or pneumothorax during 
general anesthesia. Anesthesiologists should carefully manage 
the pulmonary complications during anesthesia in LAM patients.
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